lapatinib has been researched along with metribolone in 1 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (metribolone) | Trials (metribolone) | Recent Studies (post-2010) (metribolone) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 744 | 0 | 92 |
| Protein | Taxonomy | lapatinib (IC50) | metribolone (IC50) |
|---|---|---|---|
| Sex hormone-binding globulin | Rattus norvegicus (Norway rat) | 0.0037 | |
| Androgen receptor | Homo sapiens (human) | 0.004 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.002 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, MC; Huang, CC; Huang, PH; Lee, YT; Lin, H; Wang, HY; Yue, CH | 1 |
1 other study(ies) available for lapatinib and metribolone
| Article | Year |
|---|---|
Suppression of breast cancer cell growth by Her2-reduced AR serine 81 phosphorylation.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Humans; Lapatinib; Metribolone; Molecular Targeted Therapy; Phosphorylation; Quinazolines; Receptor, ErbB-2; Receptors, Androgen | 2016 |